Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AtriCure, Inc. stock logo
ATRC
AtriCure
$54.54
+3.0%
$42.41
$25.36
$55.72
$2.69B1.26835,279 shs1.10 million shs
AxoGen, Inc. stock logo
AXGN
AxoGen
$42.16
+0.7%
$45.20
$15.27
$52.91
$2.25B1.16935,070 shs3.48 million shs
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$70.94
-0.6%
$81.96
$36.53
$97.59
$2.13B1.05360,049 shs281,967 shs
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
$3.31
+0.3%
$3.63
$3.11
$10.00
$661.27M-1.9441,516 shs84,990 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AtriCure, Inc. stock logo
ATRC
AtriCure
+2.98%+5.86%+25.21%+89.44%+55.16%
AxoGen, Inc. stock logo
AXGN
AxoGen
+0.74%-12.68%-15.12%-1.95%+162.35%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-0.63%-4.51%-6.14%-13.64%+87.03%
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
+0.30%-2.93%-10.30%-1.49%-47.96%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AtriCure, Inc. stock logo
ATRC
AtriCure
$54.54
+3.0%
$42.41
$25.36
$55.72
$2.69B1.26835,279 shs1.10 million shs
AxoGen, Inc. stock logo
AXGN
AxoGen
$42.16
+0.7%
$45.20
$15.27
$52.91
$2.25B1.16935,070 shs3.48 million shs
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$70.94
-0.6%
$81.96
$36.53
$97.59
$2.13B1.05360,049 shs281,967 shs
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
$3.31
+0.3%
$3.63
$3.11
$10.00
$661.27M-1.9441,516 shs84,990 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AtriCure, Inc. stock logo
ATRC
AtriCure
+2.98%+5.86%+25.21%+89.44%+55.16%
AxoGen, Inc. stock logo
AXGN
AxoGen
+0.74%-12.68%-15.12%-1.95%+162.35%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-0.63%-4.51%-6.14%-13.64%+87.03%
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
+0.30%-2.93%-10.30%-1.49%-47.96%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AtriCure, Inc. stock logo
ATRC
AtriCure
2.75
Moderate Buy$52.00-4.66% Downside
AxoGen, Inc. stock logo
AXGN
AxoGen
2.75
Moderate Buy$51.5622.29% Upside
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
2.78
Moderate Buy$100.2541.32% Upside
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
1.00
Sell$7.00111.48% Upside

Current Analyst Ratings Breakdown

Latest SSII, ATRC, AXGN, and ESTA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/2/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Boost Price TargetBuy$45.00 ➝ $64.00
9/1/2026
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Reiterated RatingBuy$103.00
8/27/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Boost Price TargetOverweight$50.00 ➝ $60.00
8/26/2026
AxoGen, Inc. stock logo
AXGN
AxoGen
Reiterated RatingSell (D-)
8/26/2026
AxoGen, Inc. stock logo
AXGN
AxoGen
Initiated CoverageBuy$60.00
8/24/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
DowngradeStrong-BuyHold
8/24/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Boost Price TargetBuy$45.00 ➝ $55.00
8/19/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
UpgradeSell (D+)Hold (C-)
8/13/2026
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
UpgradeNeutralBuy$92.00
8/7/2026
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Boost Price TargetOverweight$84.00 ➝ $95.00
8/6/2026
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Set Price Target$105.00
(Data available from 9/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AtriCure, Inc. stock logo
ATRC
AtriCure
$534.53M5.19$0.32 per share169.21$9.89 per share5.51
AxoGen, Inc. stock logo
AXGN
AxoGen
$225.21M10.06N/AN/A$2.79 per share15.11
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$245.82M8.60N/AN/A$0.81 per share87.58
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
$52.40M12.66N/AN/A$0.20 per share16.55
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AtriCure, Inc. stock logo
ATRC
AtriCure
-$11.45M$0.21259.73121.20N/A1.85%2.34%1.77%11/4/2026 (Estimated)
AxoGen, Inc. stock logo
AXGN
AxoGen
-$15.70M-$0.68N/A843.20N/A-13.36%-8.90%-6.47%11/4/2026 (Estimated)
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$51.06M-$1.31N/A7,094.00N/A-15.82%-196.69%-10.73%11/4/2026 (Estimated)
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
-$12.13M-$0.06N/AN/AN/A-23.73%-26.77%-15.01%N/A

Latest SSII, ATRC, AXGN, and ESTA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
N/A-$0.01N/A-$0.01N/A$13.94 million
8/6/2026Q2 2026
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$0.3368-$0.39-$0.0532-$0.39$65.79 million$67.54 million
7/29/2026Q2 2026
AxoGen, Inc. stock logo
AXGN
AxoGen
$0.1214$0.12-$0.0014-$0.03$67.10 million$69.73 million
7/23/2026Q2 2026
AtriCure, Inc. stock logo
ATRC
AtriCure
-$0.0017$0.18+$0.1817$0.18$151.80 million$153.60 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AtriCure, Inc. stock logo
ATRC
AtriCure
N/AN/AN/AN/AN/A
AxoGen, Inc. stock logo
AXGN
AxoGen
N/AN/AN/AN/AN/A
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
N/AN/AN/AN/AN/A
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AtriCure, Inc. stock logo
ATRC
AtriCure
0.14
4.22
3.19
AxoGen, Inc. stock logo
AXGN
AxoGen
0.07
6.60
5.04
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
12.11
3.84
2.52
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
N/A
2.24
1.66

Institutional Ownership

CompanyInstitutional Ownership
AtriCure, Inc. stock logo
ATRC
AtriCure
99.11%
AxoGen, Inc. stock logo
AXGN
AxoGen
80.29%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
72.91%
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
N/A

Insider Ownership

CompanyInsider Ownership
AtriCure, Inc. stock logo
ATRC
AtriCure
4.00%
AxoGen, Inc. stock logo
AXGN
AxoGen
2.44%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
9.99%
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
AtriCure, Inc. stock logo
ATRC
AtriCure
1,35050.87 million48.83 millionOptionable
AxoGen, Inc. stock logo
AXGN
AxoGen
62253.76 million52.45 millionOptionable
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
1,00429.80 million26.83 millionOptionable
SS Innovations International, Inc. stock logo
SSII
SS Innovations International
4200.39 millionN/AN/A

Recent News About These Companies

SS Innovations Provides Update on Continuing Progress and Milestones

New MarketBeat Followers Over Time

Media Sentiment Over Time

AtriCure stock logo

AtriCure NASDAQ:ATRC

$54.54 +1.58 (+2.98%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$52.26 -2.28 (-4.18%)
As of 09/11/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

AxoGen stock logo

AxoGen NASDAQ:AXGN

$42.16 +0.31 (+0.74%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$41.73 -0.43 (-1.02%)
As of 09/11/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.

Establishment Labs stock logo

Establishment Labs NASDAQ:ESTA

$70.94 -0.45 (-0.63%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$70.94 0.00 (-0.01%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

SS Innovations International stock logo

SS Innovations International NASDAQ:SSII

$3.31 +0.01 (+0.30%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$3.32 +0.01 (+0.21%)
As of 09/11/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AVRA Medical Robotics, Inc. develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc. and changed its name to AVRA Medical Robotics, Inc. in November 2015. AVRA Medical Robotics, Inc. was founded in 2015 and is based in Orlando, Florida.